nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—polycystic ovary syndrome	0.893	1	CbGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—S100P—polycystic ovary syndrome	0.00975	0.215	CbGpPWpGaD
Moxifloxacin—White blood cell count increased—Metformin—polycystic ovary syndrome	0.00637	0.114	CcSEcCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HELLS—polycystic ovary syndrome	0.00427	0.094	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.00405	0.0892	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—CCNE2—polycystic ovary syndrome	0.00308	0.0678	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.00307	0.0676	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—CDC6—polycystic ovary syndrome	0.00289	0.0638	CbGpPWpGaD
Moxifloxacin—Fungal infection—Metformin—polycystic ovary syndrome	0.00166	0.0297	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.00157	0.0346	CbGpPWpGaD
Moxifloxacin—Chest discomfort—Metformin—polycystic ovary syndrome	0.00144	0.0259	CcSEcCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—polycystic ovary syndrome	0.00131	0.029	CbGpPWpGaD
Moxifloxacin—Neuropathy—Metformin—polycystic ovary syndrome	0.0012	0.0215	CcSEcCtD
Moxifloxacin—Enoxacin—TOP2A—polycystic ovary syndrome	0.00118	0.185	CrCbGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00114	0.025	CbGpPWpGaD
Moxifloxacin—Ear pain—Metformin—polycystic ovary syndrome	0.00109	0.0195	CcSEcCtD
Moxifloxacin—Sparfloxacin—TOP2A—polycystic ovary syndrome	0.00108	0.17	CrCbGaD
Moxifloxacin—Injury—Metformin—polycystic ovary syndrome	0.00101	0.0181	CcSEcCtD
Moxifloxacin—Renal impairment—Metformin—polycystic ovary syndrome	0.000975	0.0175	CcSEcCtD
Moxifloxacin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000951	0.017	CcSEcCtD
Moxifloxacin—Lethargy—Metformin—polycystic ovary syndrome	0.000947	0.017	CcSEcCtD
Moxifloxacin—Pain in extremity—Metformin—polycystic ovary syndrome	0.000928	0.0166	CcSEcCtD
Moxifloxacin—Migraine—Metformin—polycystic ovary syndrome	0.000913	0.0164	CcSEcCtD
Moxifloxacin—Lomefloxacin—TOP2A—polycystic ovary syndrome	0.00089	0.14	CrCbGaD
Moxifloxacin—Dehydration—Metformin—polycystic ovary syndrome	0.000863	0.0155	CcSEcCtD
Moxifloxacin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000857	0.0154	CcSEcCtD
Moxifloxacin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000847	0.0152	CcSEcCtD
Moxifloxacin—Breast disorder—Metformin—polycystic ovary syndrome	0.000838	0.015	CcSEcCtD
Moxifloxacin—Cramp muscle—Metformin—polycystic ovary syndrome	0.000835	0.015	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.000833	0.0184	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.000825	0.0182	CbGpPWpGaD
Moxifloxacin—Abdominal distension—Metformin—polycystic ovary syndrome	0.000807	0.0145	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.000799	0.0176	CbGpPWpGaD
Moxifloxacin—Pancreatitis—Metformin—polycystic ovary syndrome	0.000786	0.0141	CcSEcCtD
Moxifloxacin—Angina pectoris—Metformin—polycystic ovary syndrome	0.000781	0.014	CcSEcCtD
Moxifloxacin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000769	0.0138	CcSEcCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—polycystic ovary syndrome	0.000766	0.0169	CbGpPWpGaD
Moxifloxacin—Levofloxacin—TOP2A—polycystic ovary syndrome	0.000761	0.12	CrCbGaD
Moxifloxacin—Ofloxacin—TOP2A—polycystic ovary syndrome	0.000761	0.12	CrCbGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.000751	0.0165	CbGpPWpGaD
Moxifloxacin—Neutropenia—Metformin—polycystic ovary syndrome	0.00075	0.0134	CcSEcCtD
Moxifloxacin—Ciprofloxacin—TOP2A—polycystic ovary syndrome	0.000735	0.116	CrCbGaD
Moxifloxacin—Infestation NOS—Metformin—polycystic ovary syndrome	0.000715	0.0128	CcSEcCtD
Moxifloxacin—Infestation—Metformin—polycystic ovary syndrome	0.000715	0.0128	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000701	0.0126	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000676	0.0121	CcSEcCtD
Moxifloxacin—Bradycardia—Metformin—polycystic ovary syndrome	0.000653	0.0117	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.000652	0.0144	CbGpPWpGaD
Moxifloxacin—Rhinitis—Metformin—polycystic ovary syndrome	0.000643	0.0115	CcSEcCtD
Moxifloxacin—Hepatitis—Metformin—polycystic ovary syndrome	0.000642	0.0115	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000639	0.0115	CcSEcCtD
Moxifloxacin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000632	0.0113	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000632	0.0139	CbGpPWpGaD
Moxifloxacin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000631	0.0113	CcSEcCtD
Moxifloxacin—Norfloxacin—TOP2A—polycystic ovary syndrome	0.000617	0.0972	CrCbGaD
Moxifloxacin—Eye disorder—Metformin—polycystic ovary syndrome	0.0006	0.0108	CcSEcCtD
Moxifloxacin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000596	0.0107	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.000586	0.0129	CbGpPWpGaD
Moxifloxacin—Angiopathy—Metformin—polycystic ovary syndrome	0.000582	0.0104	CcSEcCtD
Moxifloxacin—Immune system disorder—Metformin—polycystic ovary syndrome	0.00058	0.0104	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000578	0.0104	CcSEcCtD
Moxifloxacin—Chills—Metformin—polycystic ovary syndrome	0.000576	0.0103	CcSEcCtD
Moxifloxacin—Malnutrition—Metformin—polycystic ovary syndrome	0.000559	0.01	CcSEcCtD
Moxifloxacin—Erythema—Metformin—polycystic ovary syndrome	0.000559	0.01	CcSEcCtD
Moxifloxacin—Flatulence—Metformin—polycystic ovary syndrome	0.000551	0.00987	CcSEcCtD
Moxifloxacin—Dysgeusia—Metformin—polycystic ovary syndrome	0.000547	0.00981	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000539	0.0119	CbGpPWpGaD
Moxifloxacin—Muscle spasms—Metformin—polycystic ovary syndrome	0.000537	0.00963	CcSEcCtD
Moxifloxacin—Vision blurred—Metformin—polycystic ovary syndrome	0.000527	0.00944	CcSEcCtD
Moxifloxacin—Tremor—Metformin—polycystic ovary syndrome	0.000523	0.00939	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000518	0.0093	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.00051	0.0112	CbGpPWpGaD
Moxifloxacin—Malaise—Metformin—polycystic ovary syndrome	0.000504	0.00903	CcSEcCtD
Moxifloxacin—Syncope—Metformin—polycystic ovary syndrome	0.000501	0.00898	CcSEcCtD
Moxifloxacin—Palpitations—Metformin—polycystic ovary syndrome	0.000494	0.00885	CcSEcCtD
Moxifloxacin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000491	0.00881	CcSEcCtD
Moxifloxacin—Hypertension—Metformin—polycystic ovary syndrome	0.000482	0.00865	CcSEcCtD
Moxifloxacin—Myalgia—Metformin—polycystic ovary syndrome	0.000476	0.00853	CcSEcCtD
Moxifloxacin—Chest pain—Metformin—polycystic ovary syndrome	0.000476	0.00853	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000472	0.00847	CcSEcCtD
Moxifloxacin—Discomfort—Metformin—polycystic ovary syndrome	0.00047	0.00843	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000456	0.01	CbGpPWpGaD
Moxifloxacin—Oedema—Metformin—polycystic ovary syndrome	0.000456	0.00818	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.000452	0.00995	CbGpPWpGaD
Moxifloxacin—Shock—Metformin—polycystic ovary syndrome	0.000449	0.00804	CcSEcCtD
Moxifloxacin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000447	0.00802	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000446	0.00801	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.000444	0.00979	CbGpPWpGaD
Moxifloxacin—Skin disorder—Metformin—polycystic ovary syndrome	0.000443	0.00794	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000441	0.0079	CcSEcCtD
Moxifloxacin—Anorexia—Metformin—polycystic ovary syndrome	0.000435	0.00779	CcSEcCtD
Moxifloxacin—Hypotension—Metformin—polycystic ovary syndrome	0.000426	0.00764	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000415	0.00745	CcSEcCtD
Moxifloxacin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000409	0.00734	CcSEcCtD
Moxifloxacin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000407	0.00729	CcSEcCtD
Moxifloxacin—Somnolence—Metformin—polycystic ovary syndrome	0.000405	0.00727	CcSEcCtD
Moxifloxacin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000401	0.0072	CcSEcCtD
Moxifloxacin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000396	0.00711	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.000395	0.0087	CbGpPWpGaD
Moxifloxacin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000394	0.00706	CcSEcCtD
Moxifloxacin—Fatigue—Metformin—polycystic ovary syndrome	0.000393	0.00705	CcSEcCtD
Moxifloxacin—Constipation—Metformin—polycystic ovary syndrome	0.00039	0.00699	CcSEcCtD
Moxifloxacin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000376	0.00674	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000373	0.00669	CcSEcCtD
Moxifloxacin—Urticaria—Metformin—polycystic ovary syndrome	0.000362	0.0065	CcSEcCtD
Moxifloxacin—Abdominal pain—Metformin—polycystic ovary syndrome	0.00036	0.00646	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000334	0.00735	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP1A1—polycystic ovary syndrome	0.00033	0.052	CrCbGaD
Moxifloxacin—Asthenia—Metformin—polycystic ovary syndrome	0.000327	0.00587	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.000323	0.00712	CbGpPWpGaD
Moxifloxacin—Pruritus—Metformin—polycystic ovary syndrome	0.000323	0.00579	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000314	0.00691	CbGpPWpGaD
Moxifloxacin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000312	0.00559	CcSEcCtD
Moxifloxacin—Dizziness—Metformin—polycystic ovary syndrome	0.000302	0.00541	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000294	0.00647	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000293	0.00645	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000291	0.00641	CbGpPWpGaD
Moxifloxacin—Vomiting—Metformin—polycystic ovary syndrome	0.00029	0.0052	CcSEcCtD
Moxifloxacin—Rash—Metformin—polycystic ovary syndrome	0.000288	0.00516	CcSEcCtD
Moxifloxacin—Dermatitis—Metformin—polycystic ovary syndrome	0.000287	0.00515	CcSEcCtD
Moxifloxacin—Headache—Metformin—polycystic ovary syndrome	0.000286	0.00512	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000275	0.00607	CbGpPWpGaD
Moxifloxacin—Nausea—Metformin—polycystic ovary syndrome	0.000271	0.00486	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000262	0.00577	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000248	0.00546	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDC6—polycystic ovary syndrome	0.000246	0.00543	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000244	0.00538	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000215	0.00474	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000203	0.00447	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000201	0.00442	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RRM2—polycystic ovary syndrome	0.000192	0.00424	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000189	0.00416	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000182	0.004	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000175	0.00385	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000173	0.00381	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—LMNA—polycystic ovary syndrome	0.000169	0.00372	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000163	0.00359	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000158	0.00347	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000151	0.00332	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000146	0.00321	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000113	0.00249	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	7.49e-05	0.00165	CbGpPWpGaD
Moxifloxacin—TOP2A—endometrium—polycystic ovary syndrome	9.69e-07	0.195	CbGeAlD
Moxifloxacin—TOP2A—uterus—polycystic ovary syndrome	8.93e-07	0.179	CbGeAlD
Moxifloxacin—TOP2A—adipose tissue—polycystic ovary syndrome	8.74e-07	0.176	CbGeAlD
Moxifloxacin—TOP2A—adrenal gland—polycystic ovary syndrome	7.84e-07	0.157	CbGeAlD
Moxifloxacin—TOP2A—female gonad—polycystic ovary syndrome	7.31e-07	0.147	CbGeAlD
Moxifloxacin—TOP2A—vagina—polycystic ovary syndrome	7.26e-07	0.146	CbGeAlD
